JP Morgan reduced its stake in INNOVENT BIO (01801) by approximately 15,536,100 shares, with an average price of around HK$43.05 per share.
On September 11, Xiaomi reduced its holdings in Sino Biopharmaceutical (01801) by 15,536,147 shares, with a price of HK$43.0477 per share, totaling approximately HK$669 million.
According to the latest data from the Hong Kong Stock Exchange, on September 11, JP Morgan reduced its holdings of INNOVENT BIO (01801) by 15,536,147 shares, at a price of 43.0477 Hong Kong dollars per share, for a total amount of approximately 669 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 87,805,600 shares, with a latest shareholding percentage of 5.38%.
Related Articles
STERLING GP(01825): Wu Jing appointed as independent non-executive director.
Pacific Legend (08547): General authorization for the issuance of new shares has expired.
MGM China (02282) bought back 1.2 million shares for HK$18.758 million on September 18th.
STERLING GP(01825): Wu Jing appointed as independent non-executive director.
Pacific Legend (08547): General authorization for the issuance of new shares has expired.
MGM China (02282) bought back 1.2 million shares for HK$18.758 million on September 18th.
